A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse. 1994

E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
Department of Large Animal Medicine and Nutrition, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

The biopharmaceutical properties of four fixed trimethoprim/sulfonamide combinations were investigated in the horse. Eight fasted horses were dosed at 1 week intervals in a sequentially designed study with one intravenous (i.v.) and three oral trimethoprim/sulfadiazine (TMP/SDZ) formulations (1, 2 and 3) administered at a dose of 5 mg/kg trimethoprim (TMP) and 25 mg/kg sulfadiazine (SDZ). Plasma concentrations of each compound were monitored for 48 h. Pharmacokinetic parameters (volume of distribution, bioavailability and total body clearance) for TMP and SDZ were calculated and compared. After oral administration plasma concentrations of TMP and SDZ increased rapidly. With all three paste formulations, TMP peak plasma concentrations were attained within 2 h. SDZ mean peak plasma concentrations were reached at 2.59 +/- 0.48 h for a commercial paste (1), and at 1.84 +/- 0.66 h and 1.95 +/- 0.61 h for the two self-made formulations (2 and 3). Mean peak plasma TMP concentrations (+/- SD) were 1.72 +/- 0.36 micrograms/ml, 1.42 +/- 0.37 micrograms/ml and 1.31 +/- 0.36 micrograms/ml, and mean peak plasma SDZ concentrations 12.11 +/- 4.55 micrograms/ml, 12.72 +/- 3.47 micrograms/ml and 15.45 +/- 4.74 micrograms/ml for preparations 1, 2 and 3. The bioavailability of TMP was 67.0 +/- 20.3%, 57.7 +/- 21.6% and 60.9 +/- 18.9% and of SDZ 57.6 +/- 14.8%, 59.3 +/- 19.5% and 65.9 +/- 5.8% for SDZ for 1, 2 and 3, respectively. Following i.v. administration TMP/SDZ plasma concentration ratios approached the optimal 1:20 ratio (+/- 10%) for about 5 h, but following the oral administrations this ratio was only achieved for a very short time-span.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination

Related Publications

E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
May 2003, Veterinary research communications,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
June 2009, Journal of veterinary pharmacology and therapeutics,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
November 1978, European journal of clinical pharmacology,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
November 1981, American journal of veterinary research,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
June 1981, American journal of veterinary research,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
April 1983, American journal of veterinary research,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
December 2020, Journal of veterinary pharmacology and therapeutics,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
February 1999, Journal of veterinary pharmacology and therapeutics,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
December 1995, Journal of veterinary pharmacology and therapeutics,
E van Duijkeren, and A G Vulto, and M M Sloet van Oldruitenborghoosterbaan, and D J Mevius, and B G Kessels, and H J Breukink, and A S van Miert
July 2002, Veterinary journal (London, England : 1997),
Copied contents to your clipboard!